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Abstract: Mathematical modeling of drug delivery is of increasing academic and industrial 
importance in many aspects. In this paper we propose an optimization approach for the 
estimation of the parameters characterizing the diffusion process of a drug from a spherical 
porous polymer device to an external finite volume. The approach is based on a nonlinear 
least-squares method and a novel mathematical model which takes into consideration both 
boundary layer effect and initial burst phenomenon. A  analytical solution to the model is 
derived and a formula for the ratio of the mass released in a given time interval and the total 
mass released in infinite time is also obtained. The approach has been tested using 
experimental data of the diffusion of prednisolone 21-hemisuccinate sodium salt from 
spherical devices made of porous poly(2-hydroxyethyl methacrylate) hydrogels. The 
effectiveness and accuracy of the method are well demonstrated by the numerical results. The 
model was used to determine the diffusion parameters including the effective diffusion 
coefficient of the drug from a series of devices that vary in both the porous structure and the 
drug loading levels. The computed diffusion parameters are discussed in relation to the 





















Mathematical modeling of drug delivery is a field of significant academic and economic 
importance. This is true not only in the biopharmaceutical disciplines [1], but also in the 
increasingly active tissue engineering research field where the development of three 
dimensional scaffolds meeting the requirements of cell migration, tissue growth, and the 
transportation of nutritious chemicals such as growth factors is still a challenge [2]. An ideal 
delivery requires a device to supply and release therapeutic agents to a desired location with a 
precise therapeutic dose for a prolonged period of time [3]. The controllability of the delivery 
is dependent on many variables. These include the transport properties and the dosage of the 
drugs; the physiochemical and structural properties, he dimensions and geometry as well as 
the release mechanisms of the drug delivery systems. Effectively predicting these parameters 
and ultimately optimizing the design of a drug deliv ry system using mathematical 
approaches can significantly reduce manufacturing costs of both new and existing products 
[1].  
 
On the other hand, mathematical tools, particularly numerical partial differential equation and 
optimization techniques have been used successfully and extensively in optimum designs of 
many engineering devices such as semiconductor devices (cf., for example, [4-7]). Despite 
the success of these techniques in many areas, reports on the systematic use of advanced 
mathematical tools in the design of controlled drug delivery devices are limited in the open 
literature, except for some simple models with know analytical solutions of the diffusion 
equation (cf., for example, [8-10]). Our previous studies have shown that the mathematical 
approach is indeed useful in interpreting experimental data and establishing the relationship 
between the drug release characteristics and the mat rial structures [11, 12]. This paper 





geometry to a spherical geometry using similar mathematical tools. The drug delivery 
systems used in our studies are based on a porous matrix made of poly(2-hydroxyethyl 
methacrylate) (PHEMA) hydrogels.  
 
PHEMA is well known for its biomedical applications a  contact lenses, intraocular lenses 
and cardiovascular implants [13, 14]. Materials based on PHEMA absorb large amounts of 
water without dissolving, and in their swollen state they behave like typical gels. Therefore, 
the term hydrogels is commonly employed for them. In most applications PHEMA hydrogels 
refer to the crosslinked polymers produced by bulk polymerization which are transparent and 
contain a homogeneous polymer matrix containing pores measured in nanometers. Although 
polymers of this type allow the diffusion of various solutes, their transport properties are 
limited by effective mean pores, or mesh diameters, within the polymer. They are more suited 
for such applications as contact lenses, in which a ombination of optical clarity and limited 
diffusive characteristics is required [15]. 
 
Various methods can be used to increase the effective pore sizes of PHEMA. One of the most 
convenient methods is to polymerise the HEMA monomer in the presence of water above a 
critical level (reportedly 40-45%) (cf. [11] and the references quoted). The materials 
produced in the presence of water possess high water content and pores ranging from several 
to hundreds of microns. The biomedical applications f porous PHEMA materials include a 
novel design of an artificial cornea and an orbit implant in which the porous PHEMA skirt 
allows host cells and tissue to grow into the devic therefore preventing extrusion of the 
implants [16-18]. Our recent studies show that the porous PHEMA hydrogels represent a 
significant advance over the non-porous types in the drug delivery applications with a much 





with very simple means, less concerning about the drug stability [11, 12]. To achieve an 
optimal design of such a device, we have been investigating mathematical models for (i) 
extracting the effective diffusion coefficient of a selected drug; and (ii) further establishing 
the relationship between the diffusion characteristics and various parameters of the drug 
delivery system including the drug loading level, the porosity and the geometry of the 
polymer matrix. 
 
It is worth mentioning that drug delivery from porous PHEMA is diffusion driven.  In a 
diffusion-controlled device, the delivery of drugs is largely dependent on the diffusion 
property of the drug in a constructed device, which is often characterized by the effective 
diffusion coefficient of the drug in the material. The effective diffusion coefficient of a drug 
delivery system is a measure of the diffusion process of a drug through a selected system over 
a period of time. It is determined mainly by the properties of a polymer matrix and the 
interactions, if any, between the drug and the polymer matrix. For a given device, drug 
release profiles from the device into a finite volume during a period of time can be 
determined through laboratory experiments.  The estimation of the effective diffusion 
coefficient of the drug during the process involves two tasks. One task is to set up a 
mathematical model for the diffusion process of the device and the other is to numerically 
estimate the effective diffusion coefficient based on the model and some given information 
such as experimentally observed drug release data.  
 
In general, a diffusion process is governed by a diffusion equation with appropriate initial and 
boundary conditions. However, solving such a diffuson problem analytically is very difficult. 
Analytical and approximate solutions to several simple models can be found in [1, 19-22]. 





the diffusion region is ‘well-stirred’, i.e., the concentration of the substance in the liquid is 
uniform which is not always true. In practice, even if the liquid is ‘well stirred’ the magnitude 
of the flow velocity on the boundary of the device should be zero due to the so-called ‘no-
slip’ boundary condition. Therefore, there exists a region, called a boundary layer, near the 
boundary of the device in which the magnitude of velocity varies from zero to some positive 
value. As a result, the substance concentration is on-uniform in the boundary layer. 
Furthermore, excessive drugs may be left on the surface of the device which causes a higher 
concentration on the surface than in the subsurface of the device. It is also possible that the 
drug concentration on the surface is lower than that in the subsurface of the device if the 
device is pre-washed prior to a drug release experiment. Both of these cases may lead to an 
initial phase of the drug release that is different from the rest of the process. Therefore, it is 
desirable to determine an effective critical time separating the two phases and to extract the 
effective diffusion coefficients for the two phases.  
 
Once a diffusion model has been established, one needs to determine the effective diffusion 
coefficient using the model. A classical ‘trial-and-error’ process is neither optimal nor 
automatic. In our previous work [23], we have proposed a model for the estimation of 
effective diffusion coefficients and other critical parameters of PHEMA devices of a 2D disc 
geometry. The model was used in conjunction with a nonlinear least-squares method. Unlike 
existing ones such as those in [22], this model can handle both the initial burst and boundary 
layer effects. In the present work, we extend the techniques in [23] to devices of a spherical 
geometry (Figure 1). We first propose a basic mathematical model governing the diffusion 
process of a drug from a spherical device into a finite volume. The model is then further 
developed to include both the initial burst and the boundary layer effects. Analytical solutions 





mass diffused from the device into the external volume in a given period of time. The 
unknown parameters including the effective diffusion coefficients, the width of the boundary 
layer and the critical time in the models are determined by an optimization technique. Six 
porous PHEMA spherical devices that contain various pore structures and different levels of 
prednisolone 21-hemisuccinate sodium salt, a commonly used anti inflammation drug, are 
then prepared. The drug release experiments are condu ted and the acquired data are used to 
test the mathematical models. The full model is finally used to determine the diffusion 
parameters including the critical time for the initial burst of drugs, the effective boundary 
layer, and the effective diffusion coefficient of the drug from these devices. The drug 
diffusion characteristics are discussed in relation o the physical properties of the devices.   
 
 
Figure 1. Schematic illustration of a porous PHEMA spherical device. 
 
 
2. The mathematical methods 
2.1. The basic model and its analytical solution 
We first consider a spherical device with radius 1r  pre-loaded with an amount of drug, 
0M . 





the device and the container are concentric, as depicted in Figure 2; and 2) the release process 
is diffusion-dominant and radial because of symmetry, i.e. the concentration of drug in liquid 
is uniform for a fixed r, the diffusion process of this problem is governed by the following 
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Figure 2: A sphere device with radius 1r placed in a container with radius2r . 
 


















     (2.4) 
where 3/4 31rVd π=  is the volume of the device. To solve this problem, we use the technique 





Let )()(),( rvtutrC = . Eq. (2.1) then becomes 

















From this we have 













where 0>λ  is a constant to be determined. The above expression contains two equations: 




v λ        (2.6) 
Eq. (2.5) has the (fundamental) solution Dteu λ−=  and Eq. (2.6) is a Bessel’s equation of the 
form 
      0)/(/)1( 2 =−+′−+′′ yxxydy µλ  
with 3=d  and 0=µ . The fundamental solution to this equation is (cf., for example, [25], 
p.231) 






)(0 = is the 0th order spherical Bessel function. Therefore, the solution of (2.1) 
is of the form 
          ( ) ,),( 0 DterjtrC λλ λ −=               (2.7) 
where λ  is a parameter called the eigenvalue of the problem. To determineλ , we apply the 
boundary condition (2.2) to (2.7) to get 
      ( ) .0),( 202 =′=∂
∂ − Dterj
r
trC λλ λλ  











αααα       for ,...2,1=n        (2.8) 
Then, we have nr αλ =2   or 
             22
2 / rnn αλ =      for ,...2,1=n . 
Substituting the above nλ  into (2.7) gives 




















This is a solution to (2.1) for each ,...2,1=n .  
    





v +=          (2.9) 
with additive constants 0A  and 0B . (Note 00 =α is also a root of (2.8) and thus 0=λ  is the 
eigenvalue corresponding to this root.) Thus, (2.9) represents the steady-state solution to 
(2.1)-(2.3).  Applying the boundary condition (2.2) to (2.9) gives .00 =B  Therefore, 
combining the fundamental solutions to (2.5) and (2.6) and using the superposition principle, 























=∑ ,     (2.10) 
where nA 's are coefficients to be determined. (Recall that 00 =α and 1)0(0 =j .)  
     
Note that the steady-state solution of the problem when ∞→t  is cVMrC /),(
0=∞ , where 








0 = .        (2.11) 
































   (2.12) 
The derivation of this integral is given in the appendix. 
   
We now use the initial condition (2.3) and the above results to determinenA , for ,...2,1=n . 





















where H is the function defined in (2.4).  Multiplying both sides of the above equation by 
)/( 20
2 rrjr mα for any ,...2,1=m , integrating the resulting equation from 0 to 2r  and using 








































































































where zzzzzj /)(cos/)(sin)( 21 −= is the 1
st order spherical Bessel function (cf., for 









3= , ,....2,1=m       (2.13) 









































+= ∑ .     (2.14) 
 
This is an analytical solution to (2.1)-(2.3) in the region defined by 20 rr <<  and ∞<< t0 . 
 
2.2. Total mass released in ],0[ t  from the device 
We now derive the total mass released from the device into the container in the time interval 
















σα −= . 
Multiplying both sides of (2.14) by drddr ⋅⋅⋅ φθφsin2  and integrating the resulting equation 
over the region: πθ 20 ≤≤  , πφ ≤≤0 and 21 rrr ≤≤ , we have 































































































































































−= .  (2.15) 
 
In the above we used (2.8). When ∞→t , we have 







M −=∞  
which is the total mass released from the device into the external volume in the time interval 
],0[ ∞ . Dividing both sides of (2.15) by ∞M  gives 













































−= .    (2.16) 
This is a formula for the ratio of the mass released from the device into the liquid during the 
time interval [0,t] and the total mass release from the device in infi ite time. We comment 
that the deduction of (2.16) is based on the assumptions that the device and container are 
concentric as depicted in Figure 2 and that the diffusion in the liquid is homogeneous. These 
assumptions are normally satisfied in ideal laboratory conditions. When the assumptions are 
not satisfied, the diffusion problem (2.1)-(2.3) can only be solved by a full numerical method 
which will be discussed in a future paper. 
 
2.3. The initial burst 
A burst often appears in the initial phase of a release process. This is because, during the drug 
load process, some free drugs are left on the device surface. In this case, the initial release 
rate is substantially greater than that during the rest of the process. On the other hand, the 
initial release rate may also be much smaller than e normal rate if a device is pre-washed to 
remove the free drugs on the device surface. In both cases, it is desirable to identify the initial 
burst and its effect on the diffusion process. To characterize the initial burst, we assume that 




















where 0D  and 1D  are constants and ct is the threshold time. All of these parameters are yet to 
be determined. From Section 2.2 we see that when ctt ≤≤0 , the concentration ),( trC  is 























=∑ , ctt > ,   (2.17) 
where nA 's are coefficients to be determined. Using the same argument employed for 
determining 0A in (2.10) we have cVMA /
0
0 = . The continuity condition at ct  that 





























































































−−=    (2.18) 
for 1≥n . Combining this with (2.17) we have the expression for ),( trC  when ctt > . 
 
It is clear that when ctt ≤≤0 , 
∞M
M t  is given by (2.16) with 0DD = . Using the same argument 
























, for ctt > .  (2.19) 
 





When the liquid is well stirred, the concentration can be considered uniform in most of the 
liquid region except for a thin layer, called the boundary layer, around the device. In this 
case, the diffusion dominates the mass transfer only in the boundary layer region. For 
simplicity we assume that thickness of the boundary l yer is uniform around the device. Let 
1r denote the radius of the device, 12 rr −  the thickness of the boundary layer and 3r the radius 









Figure 3: A spherical device with radius 1r placed in a container with radius3r . 
 


























 ,0 2rr <<   0>t , 




















where 3/4 31rVd π= , the volume of the device as defined before, and )(0 tC is the (unknown) 





to 3r , the concentration is uniform. Using the results in Section 2.1 it is easy to verify that the 














trC        (2.20) 
for 0>t with the continuity condition ),()( 20 trCtC = , where ),( trC  is given by (2.14). We 
now calculate the total mass, tM , released in time t. Note that tM  contains two parts: the 
mass at t in the boundary layer region )2,0(),( 21 π×rr  and that in the convection-dominant 
region )2,0(),( 32 π×rr . The calculation of the former is exactly the same as that for (2.16) and 
the latter is just the constant concentration ),( 2 trC times the corresponding volume. 
 
Let 3/4 32rVc π= , as defined before, and 3/4ˆ
3
3rVc π= , the volume of the container. 
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M −=∞ , representing the total mass in the liquid after infin te time. Dividing 



























































































































Using (2.21) and the technique in Section 2.3 for deducing (2.19) it is easy to derive the 






is given by (2.21) with 0DD =  when ctt ≤<0  and 













































for ctt > , where ct  is the effective critical time. 
 
We comment that the thickness of the boundary layer, 12r − , can not normally be determined 
exactly. In this investigation, we treat 2r as a decision parameter in an optimization process, 
and refer to the resulting value as the eff ctive boundary layer. 
 
3.  Device preparation, drug loading and release experiments 
3.1. Chemicals and materials 
HEMA (Bimax, ophthalmic grade) was used as received. The cross-linking agent 1,5-
hexadiene-3,4-diol (DVG) with a purity of 97% was supplied by Sigma-Aldrich. An aqueous 
solution of 10 wt % ammonium persulphate (APS) (Ajax Chemicals) was used together with 
N,N,N’,N’-tetramethylethylene diamine (TEMED) (Aldrich Chemical Co.) as initiators. 
Prednisolone 21-hemissucinate sodium salt powder was purchased from Sigma Chemical 






3.2. Device preparation 
Three porous PHEMA sphercal devices, S2080, S3070 and S4060 were cast following the 
specifications given in Table 1. The formulations were selected to produce devices 
chemically identical but structurally different. The physical properties including the swelling 
behaviour, the polymer volume fraction, density of the dry and wet polymer hydrogels have 
been reported in our previous work [11, 12].  To cast the polymer devices, HEMA and water 
were well mixed in a beaker followed by the addition of the cross-linking agent (DVG) and 
the initiators (APS and TEMED). The solution was then distributed into a plastic mold as 
displayed in Figure 4a. Polymerization was carried out at room temperature for 3 hours and 
then at 50°C for 24 hours. Following the polymerisation, the samples were removed from the 
mould and immersed in deionised water for 4 weeks with daily water exchange to remove 
residual monomers and oligomers. Photographs of td the produced spherical devices are 
displayed in Figure 4b.   
 













S2080 50 200 500 1000 1000 
S3070 75 175 750 1500 1500 















3.3. Drug loading and release experiments 
Upon completion of water exchange the devices were fr eze-dried and placed in containers 
containing a drug solution of either 1.0 wt% or 0.5 wt% concentration. Sufficient drug 
solution was added to allow the maximum absorption of the drugs upon swelling of the 
devices.  
 
The drug loaded devices, S2080-10, S3070-10, S40-60-10, S2080-05, S3070-05 and S4060-
05 were then placed in the centre of a container which as an air tight seal (10 and 05 are 
used in the sample codes representing 1.0 wt% and 0.5 wt% drug solution respectively). The 
container was then filled with enough deionised water and placed upon an orbital shaker 
(Chiltern Scientific) at a speed of 45 rpm. At preset time points 500µL of the drug solution 
was removed from a marked location and further diluted for quantitative analysis of released 
drug concentrations tM using a UV-Vis spectrometer. Details of the quantittive analysis of 
drugs can be found in references [11, 12]. 
 
4. Results and discussions 
4.1. Testing the mathematical models 
In this section we will test the models established in the previous section using some 






The series solutions obtained from Section 3 contain up to four unknown parameters 
ctDD ,, 10 and 2r . To determine these parameters, a nonlinear least-squares algorithm is used as 
proposed in [23]. The algorithm is to minimize the fitting error 








−= θθ  (4.1) 
where kw is a positive constant, )( ke tR is the experimentally measured value of the ratio 
∞M





) at kt  for Kk ,...,2,1= , and )/()( 1312 rrrr −−=θ is a parameter characterizing 
the width of the boundary layer satisfying 10 ≤< θ . The quantity NR  in (4.1) is the sum of 
the first N terms of an exact solution of the ratio. For instace, NR for the solution in Section 
2.3 (i.e., (2.16) and (2.19)) is given by 
















































































(In this case 1=θ  is not a decision variable since 32 rr = .) For simplicity, we assume that 
ct only takes values from the discrete set { }Kttt ,...,, 21 . For all the tests below, we 
choose 62=N . The first 62 roots of (2.8) are calculated numerically using Matlab. To avoid 
possible local minima, the least-squares problem is solved using the following initial starting 
points 
iDD 2/10 510
−==  for 10,...,2,1=i  and j1.0=θ  for 10,...,2,1=j . 
 






In what follows, we shall refer the solution (2.16) to as Model BM, the solution (2.1) and 
(2.19) to as Model IB, (2.21) to as Model BL and (2.21) and (2.22) to as Model IB+BL. 
 
4.1.1 The effect of initial burst 
In order to see the effect of initial burst, experimental data of S2080-10, ∞MM t / , collected 
at 12 time points from 0.5 to 72.8 (Table 2) were fitt d with all four models. The radius of the 
device,1r , was measured as 0.906 cm and the radius of the effective container, i.e., 2r  in 
Models BM and IB or 3r  in Models BL and IB+BL, used in experiments is 2.037 cm.  
Table 2: Experimental data of ∞MM t / for S2080-10 and S4060-05  
Time (hour) 0.5 1.0 1.5 2.0 3.0 4.5 
S2080-10 0.577 0.671 0.675 0.686 0.697 0.732 
S4060-05 0.158 0.212 0.230 0.260 0.286 0.332 
Time (hours) 6.9 24.9 32.7 51.0 55.8 72.8 
S2080-10 0.866 0.934 0.963 0.989 0.980 1.000 
S4060-05 0.365 0.645 0.781 0.971 0.973 1.000 
 
The fitted curves using the four models BM, IB, BL and IB+BL are displayed in Figure 5. 
The curves fitted by BM and BL are almost identical, so are those fitted by IB and IB+BL 
which indicate an insignificant boundary layer effect for the selected device. On the other 
hand, an apparent initial burst from device S2080-10 is identified by both IB and IB+BL. The 
fittings by Models IB and IB+BL are more satisfactory than those by Models BM and BL. 
The more adequate approximation by Models IB and IB+BL is also demonstrated by a ten-
fold smaller value of the lease squares error of these methods in comparison with the other 






Figure 5: Fitted curves by the four mathematical models for S2080-10. 
 








4.1.2. The effective boundary layer 
To determine the effective boundary layer, similar fittings were performed on the 
experimental data from the device S4060-05 (Table 2). The fitted curves from the four 
models are displayed in Figure 6 and the computed optimal parameters are listed in Table 4. 
In this case, a minor drug burst during the first two hours is revealed by both IB and IB+BL 
(Fig. 6). In addition, effective boundary layers, measured as θ = 93% and 84%, are identified 
Model Diffusivity( cm2/s) tc (hour) θ  Least-squares Error 
BM 1.56E-5 __ __ 2.81E-2 
IB (4.13E-5,3.65E-6) 1.0 __ 2.85E-3 
BL 1.56E-5 __ 1.00 2.81E-2 





by BL and IB+BL respectively (Table 4). For this particular device, the computed values of 
the effective diffusion coefficient from the four models are similar. However, the best fit is 
obtained by the combined model IB+BL which is demonstrated by the smallest least squares 
error of the fitting.  
 
Figure 6: Fitted curves by the four mathematical models for S4060-05. 
 








4.2.  Determination of the diffusion parameters  
Applying the four mathematical models to the experim ntal data of all investigated devices 
Model Diffusivity( cm2/s) tc (hour) θ  Least-squares Error 
BM 1.55E-6 __ __ 5.51E-2 
IB (1.25E-6, 1.86E-6) 2.0 __ 5.28E-2 
BL 2.10E-6 __ 0.93 3.69E-2 





has indicated that, 1) models IB and IB+BL yield better fitting and approximation results 
when an initial burst of drugs occurs, 2) the effective boundary layers are not always present 
in the spherical devices investigated in this study, however when the effect is apparent, 
models BL and IB+BL are more efficient to identify the phenomenon, and 3) in all devices, 
the combined model IB+BL has produced more satisfactory results than the individual 
models developed, judged by both the ability to identify the effect of the initial burst and the 
effective boundary layers, as well as by the smaller least square errors. Therefore only the 
computed parameters from Model IB+BL are listed andused for further discussions (Table 
5). Fittings of all experimental data by the combined model are shown in Figure 7a and 7b.    
 
Table 5: Computed diffusion parameters of all devices by Model IB+BL 
Diffusion coefficient ( scm /2 ) 
Device 
D0 D1 
θ  hour)(ct  Least-squares Error 
S2080-10 4.13E-05 3.65E-06 1.00 1.0 2.85E-03 
S3070-10 5.03E-06 2.30E-06 1.00 1.0         5.04E-03 
S4060-10 1.49E-05 2.20E-06 0.92 1.0 5.11E-03 
S2080-05 6.01E-06 2.83E-06 0.98 1.0 7.67E-03 
S3070-05 3.44E-06 2.02E-06 0.94 2.0 8.35E-03 
S4060-05 2.94E-05 2.00E-06 0.84 0.5 2.44E-02 
  
4.3. Comparison of the diffusion parameters 
The computed parameters listed in Table 5 demonstrate th t the corrected effective diffusion 
coefficient, 1D , of S2080 is greater than that of S3070, and greate  still than that of S4060 at 
both drug loading levels. The descending trend of 1D in devices loaded with 1.0 wt% drug 





observations are coincide with the fact that S2080 has a more porous structure than the other 
two devices and are also in agreement with our previous results on the disc geometry [11, 
12].  We have also noticed that the initial burst effect in S2080 is more significant than in the 
other two devices (Table 3 and 5), indicating that the drugs are more prone to burst from 
S2080 due to its softer and more porous nature. 
 
 
                              (a)         (b) 
Figure 7: Fitted curves by Model IB+BL for devices loaded with (a) 1.0 wt% and (b) 0.5 
wt% drug solutions. 
   
5. Conclusions 
In this work we have developed a full mathematical model for extracting effective parameters 
such as diffusion coefficients, critical time of init al burst and width of boundary layers that 
determine the release process of a drug from a spherical device into a finite volume. The 
model contains three other simpler models as special cases. Explicit expressions for the 
analytical solutions of these models have been obtained which contain the parameters as 
unknown decision variables. A nonlinear least-squares method is then used for finding the 
optimal solutions to these parameters, yielding an optimal fit to a set of experimental data. 





release devices made of porous hydrogel polymers with t o different drug loading levels to 
show the accuracy and usefulness of the models. The results demonstrated that the full 
mathematical model can effectively identify both the drug burst effect and the effective 
boundary layer, if any, and therefore can more accurately determine the diffusion parameters 
that govern a true diffusion process, whilst the thr e simpler models are effective only for the 
uncontaminated experimental data. The computed diffusion parameters are explicable in 
terms of the drug loading concentrations and the porous structure of the devices and are 
generally consistent with the results obtained from our previous studies on the disc geometry. 
Full numerical methods such as those in references [26, 27] are under development for 
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Appendix : Derivation of (2.12) 
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